Journal list menu
IssueCancer Communications: Volume 42, Issue 6
i-ii, 491-579June 2022
Export Citations
Download PDFs
FEATURED COVER
Cover Image, Volume 42, Issue 6
- Page: i
- First Published: 14 June 2022
The cover image is based on the Review Article Epi-immunotherapy for cancers by Wenbin Qian et al., https://doi.org/10.1002/cac2.12313.
ADDITIONAL COVER
Cover Image, Volume 42, Issue 6
- Page: ii
- First Published: 14 June 2022
The cover image is based on the Letter to Editor Proteomic identification of new diagnostic biomarkers of early-stage cutaneous mycosis fungoides by Ling Leng et al., https://doi.org/10.1002/cac2.12266.
ISSUE INFORMATION
REVIEW
Epi-immunotherapy for cancers: rationales of epi-drugs in combination with immunotherapy and advances in clinical trials
- Pages: 493-516
- First Published: 01 June 2022
ORIGINAL ARTICLES
Spatial metabolomics for evaluating response to neoadjuvant therapy in non-small cell lung cancer patients
- Pages: 517-535
- First Published: 20 May 2022
Crosstalk between IL-15Rα+ tumor-associated macrophages and breast cancer cells reduces CD8+ T cell recruitment
- Pages: 536-557
- First Published: 25 May 2022
LETTERS TO THE EDITOR
Proteomic identification of new diagnostic biomarkers of early-stage cutaneous mycosis fungoides
- Pages: 558-562
- First Published: 20 January 2022
Gene expression profiling improves prognostication by nomogram in patients with soft-tissue sarcomas
- Pages: 563-566
- First Published: 07 February 2022
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple-negative breast cancer models
- Pages: 567-571
- First Published: 16 March 2022
Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer
- Pages: 572-575
- First Published: 09 April 2022
Childhood overweight and risk of obesity-related adult cancer in men
- Pages: 576-579
- First Published: 08 April 2022
Sign up for email alerts
Tools
More from this journal
Cancer collection based on different tumor types
Information for Authors
Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.
Impact Factors in Journal Citation Report (2018, Clarivate) are under the previous journal title Chinese Journal of Cancer.
Archival Content
To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.
Understanding Open Access
As an open access journal, all articles in Cancer Communications are freely available to read, download and share immediately on publication.
Relevant Open – Access Health Sciences journals
Aging AND Cancer (2020-Present)
Cancer Innovation (2022-Present)
Clinical and Translational Medicine (2012-Present)
MedComm (2020-Present)
MedComm – Oncology (2022-Present)